These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22647715)

  • 1. Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway.
    Klucken J; Poehler AM; Ebrahimi-Fakhari D; Schneider J; Nuber S; Rockenstein E; Schlötzer-Schrehardt U; Hyman BT; McLean PJ; Masliah E; Winkler J
    Autophagy; 2012 May; 8(5):754-66. PubMed ID: 22647715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
    Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
    Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype.
    Minakaki G; Menges S; Kittel A; Emmanouilidou E; Schaeffner I; Barkovits K; Bergmann A; Rockenstein E; Adame A; Marxreiter F; Mollenhauer B; Galasko D; Buzás EI; Schlötzer-Schrehardt U; Marcus K; Xiang W; Lie DC; Vekrellis K; Masliah E; Winkler J; Klucken J
    Autophagy; 2018; 14(1):98-119. PubMed ID: 29198173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.
    Crews L; Spencer B; Desplats P; Patrick C; Paulino A; Rockenstein E; Hansen L; Adame A; Galasko D; Masliah E
    PLoS One; 2010 Feb; 5(2):e9313. PubMed ID: 20174468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein.
    Ebrahimi-Fakhari D; Cantuti-Castelvetri I; Fan Z; Rockenstein E; Masliah E; Hyman BT; McLean PJ; Unni VK
    J Neurosci; 2011 Oct; 31(41):14508-20. PubMed ID: 21994367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of ATP13A2 leads to lysosomal dysfunction, α-synuclein accumulation, and neurotoxicity.
    Usenovic M; Tresse E; Mazzulli JR; Taylor JP; Krainc D
    J Neurosci; 2012 Mar; 32(12):4240-6. PubMed ID: 22442086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p62/SQSTM1-dependent autophagy of Lewy body-like α-synuclein inclusions.
    Watanabe Y; Tatebe H; Taguchi K; Endo Y; Tokuda T; Mizuno T; Nakagawa M; Tanaka M
    PLoS One; 2012; 7(12):e52868. PubMed ID: 23300799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
    Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein fate is determined by USP9X-regulated monoubiquitination.
    Rott R; Szargel R; Haskin J; Bandopadhyay R; Lees AJ; Shani V; Engelender S
    Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18666-71. PubMed ID: 22065755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMBRA1, a novel α-synuclein-binding protein, is implicated in the pathogenesis of multiple system atrophy.
    Miki Y; Tanji K; Mori F; Tatara Y; Utsumi J; Sasaki H; Kakita A; Takahashi H; Fimia GM; Wakabayashi K
    Brain Pathol; 2018 Jan; 28(1):28-42. PubMed ID: 27875637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo.
    Wu J; Lou H; Alerte TN; Stachowski EK; Chen J; Singleton AB; Hamilton RL; Perez RG
    Neuroscience; 2012 Apr; 207():288-97. PubMed ID: 22326202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.
    Klucken J; Ingelsson M; Shin Y; Irizarry MC; Hedley-Whyte ET; Frosch M; Growdon J; McLean P; Hyman BT
    Acta Neuropathol; 2006 Feb; 111(2):101-8. PubMed ID: 16482476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of beta-synuclein in cortical neurons is associated with autophagy attenuation in the brains of dementia with Lewy body patients.
    Evans T; Kok WL; Cowan K; Hefford M; Anichtchik O
    Brain Res; 2018 Feb; 1681():1-13. PubMed ID: 29278715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice.
    Rocha EM; Smith GA; Park E; Cao H; Graham AR; Brown E; McLean JR; Hayes MA; Beagan J; Izen SC; Perez-Torres E; Hallett PJ; Isacson O
    Antioxid Redox Signal; 2015 Aug; 23(6):550-64. PubMed ID: 26094487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trehalose intake induces chaperone molecules along with autophagy in a mouse model of Lewy body disease.
    Tanji K; Miki Y; Maruyama A; Mimura J; Matsumiya T; Mori F; Imaizumi T; Itoh K; Wakabayashi K
    Biochem Biophys Res Commun; 2015 Oct; 465(4):746-52. PubMed ID: 26299928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease.
    Zhou W; Milder JB; Freed CR
    J Biol Chem; 2008 Apr; 283(15):9863-70. PubMed ID: 18238775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice.
    Casadei N; Pöhler AM; Tomás-Zapico C; Torres-Peraza J; Schwedhelm I; Witz A; Zamolo I; De Heer R; Spruijt B; Noldus LP; Klucken J; Lucas JJ; Kahle PJ; Krüger R; Riess O; Nuber S
    Hum Mol Genet; 2014 Feb; 23(3):767-81. PubMed ID: 24064336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers.
    Umeda T; Hatanaka Y; Sakai A; Tomiyama T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.